advanced - International Biopharmaceutical Industry

Current Edition

Volume 5 Issue 3

Why Regulatory Convergence is Key to Global Development of Cell and Gene Therapies

There is growing excitement about the potential shown by cell and gene therapies, particularly in rare diseases. First, though, these therapies face challenges both i...

12 October 2022 Volume 5 Issue 3 achieving | advanced

Continue Reading →

news

Merck’s Keytruda gets approval in China for advanced melanoma

Melanoma is one of the fastest growing malignant cancers in China, increasing at an annual rate of 3-5 percent, which makes it one of the deadliest diseases in the co...

31 July 2018 news advanced | approval

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

Why Regulatory Convergence is Key to Global Development of Cell and Gene Therapies

Merck’s Keytruda gets approval in China for advanced melanoma

International Biopharmaceutical Industry